Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
/PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company, announced today the completion of a $73 million financing...
Source: prnewswire.com